Literature DB >> 28970333

Will GRPR Compete with PSMA as a Target in Prostate Cancer?

Andrei Iagaru1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28970333     DOI： 10.2967/jnumed.117.198192

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  7 in total

1.  The Utility of [18F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography.

Authors:  Corinne Beinat; Tom Haywood; Yun-Sheng Chen; Chirag B Patel; Israt S Alam; Surya Murty; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

2.  Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.

Authors:  Paige M Glumac; Joseph P Gallant; Mariya Shapovalova; Yingming Li; Paari Murugan; Shilpa Gupta; Ilsa M Coleman; Peter S Nelson; Scott M Dehm; Aaron M LeBeau
Journal:  Clin Cancer Res       Date:  2019-11-15       Impact factor: 12.531

3.  NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.

Authors:  Aikaterini Kaloudi; Emmanouil Lymperis; Athina Giarika; Simone Dalm; Francesca Orlandi; Donato Barbato; Mattia Tedesco; Theodosia Maina; Marion de Jong; Berthold A Nock
Journal:  Molecules       Date:  2017-11-11       Impact factor: 4.411

Review 4.  The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research.

Authors:  Eline A M Ruigrok; Wytske M van Weerden; Julie Nonnekens; Marion de Jong
Journal:  Pharmaceutics       Date:  2019-10-29       Impact factor: 6.525

5.  Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer.

Authors:  Maryana Handula; Marjolein Verhoeven; Kuo-Ting Chen; Joost Haeck; Marion de Jong; Simone U Dalm; Yann Seimbille
Journal:  Pharmaceutics       Date:  2022-01-14       Impact factor: 6.321

6.  68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data.

Authors:  Paola Mapelli; Samuele Ghezzo; Ana Maria Samanes Gajate; Erik Preza; Anna Palmisano; Vito Cucchiara; Giorgio Brembilla; Carolina Bezzi; Riccardo Rigamonti; Patrizia Magnani; Elisa Toninelli; Valentino Bettinardi; Nazareno Suardi; Luigi Gianolli; Paola Scifo; Alberto Briganti; Francesco De Cobelli; Antonio Esposito; Maria Picchio
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

Review 7.  Radiolabeled PSMA Inhibitors.

Authors:  Oliver C Neels; Klaus Kopka; Christos Liolios; Ali Afshar-Oromieh
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.